Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis. (Q34022160)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Tomasz Rakowski

object named as

T Rakowski

11

0 references

author name string

G DE Luca

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

F Bellandi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

K Huber

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M Noc

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A S Petronio

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

H-R Arntz

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

H M Gabriel

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Zorman

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M Gyongyosi

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

D Dudek

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 December 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

2361-2370

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21929513%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Bias in location and selection of studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Impact of early abciximab administration on infarct size in patients with ST-elevation myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Facilitated PCI in patients with ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction Dichotomous response as a function of age in the GUSTO V trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

1-Year Survival in a Randomized Trial of Facilitated Reperfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Composition of coronary thrombus in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04513.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34022160&oldid=1653362625"